Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study

This publication has 45 references indexed in Scilit:

• Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population‐Based Study in Germany
  Hepatology Communications, 2022
• NT-proBNP as a Marker for Atrial Fibrillation and Heart Failure in Four Observational Outpatient Trials
  ESC Heart Failure, 2021
• MicroRNAs sequencing of plasma exosomes derived from patients with atrial fibrillation: miR-124-3p promotes cardiac fibroblast activation and proliferation by regulating AXIN1
  Journal of Physiology and Biochemistry, 2021
• Serum extracellular vesicles containing MIAT induces atrial fibrosis, inflammation and oxidative stress to promote atrial remodeling and atrial fibrillation via blockade of miR‐485‐5p‐mediated CXCL10 inhibition
  Clinical and Translational Medicine, 2021
• CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study
  Journal of Cardiovascular Translational Research, 2016
• Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes
  Hepatology, 2015
• Die Gutenberg Gesundheitsstudie
  Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2012
• The NAFLD fibrosis score
  Hepatology, 2007
• Subclinical Atherosclerosis and Risk of Atrial Fibrillation
  Archives of internal medicine (1960), 2007
• Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
  Hepatology, 2006